# US 2003/0224370 A1 · Method and apparatus for recognizing molecular compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224370 A1
- Document ID: US20030224370A1
- Status: Published application
- Kind: A1
- Application number: 10/158,995
- Filed: 2002-05-31
- Published: 2003-12-04
- Earliest claimed: 2002-05-31
- Inventors: William Rassman; David Ralin; Feiming Zhou; Shubo Han
- Web page: https://patentgrep.com/patent/US20030224370A1

## CPC

- G01N 33/5306: {Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding}
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- G01N 21/552: Attenuated total reflection
- B01J 2219/00581: Mass
- B01J 2219/00605: the compounds being directly bound or immobilised to solid supports
- B01J 2219/00612: the surface being inorganic
- B01J 2219/00702: Processes involving means for analysing and characterising the products
- C40B 70/00: Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
- G01N 2021/212: {Arrangement with total internal reflection}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

A probe-target reaction is made more recognizable by the provision of a mass-enhancing and/or evanescent-field-perturbing amplifier element which reacts uniquely with and binds to the probe-target pair to provide increased mass. Where the probe-target pair is hybridized dsDNA, a suitable mass-enhancing amplifier is anti-double stranded DNA mouse IgM. In examples with sufficient sequence pairs in the probe-target combination, a sequence-specific minor-groove-binding polyamide can be used that carries biotin which can be amplified by streptavidin in a suitable carrier. In a preferred embodiment, a plurality of probes are immobilized at the sites of a microarray, each probe being specific to a different target. Optics utilizing total internal reflection are described for observing perturbation of the evanescent field.

## Claims

### Claim 1

A method of discriminating between binding and nonbinding molecular targets of a molecular probe, the method comprising the steps of:
providing a substrate, said substrate forming a surface and an evanescent optical field proximate said surface;
immobilizing a molecular probe on said surface;
exposing said molecular probe to a solution containing said molecular target;
selectively perturbing said evanescent optical field only if said molecular target has bound to said molecular probe;
observing said evanescent field; and
correlating perturbation of said evanescent field with binding of said molecular target to said molecular probe.

### Claim 2 (depends on 1)

A method as set forth in claim 1, wherein:
said substrate utilizes total internal reflection to form said evanescent field;
said molecular probe comprises a nucleic acid having a single-stranded segment;
said molecular target comprises a nucleic acid having a single-stranded segment tending to hybridize with said single-stranded segment of said molecular probe and thereby to form a double-stranded segment; and
said step of selectively perturbing said evanescent optical field includes the step of exposing said surface to a solution containing an immunoglobulin tending selectively to bind to said double-stranded segment.

### Claim 3 (depends on 2)

A method as set forth in claim 2, wherein said step of selectively perturbing said evanescent optical field further includes the step of exposing said surface to a solution containing a material tending selectively to bind to said immunoglobulin.

### Claim 4 (depends on 1)

A method as set forth in claim 1, wherein:
said substrate utilizes total internal reflection to form said evanescent field;
said molecular probe comprises an immunoglobulin; and
said molecular target comprises an antigen tending to bind to said immunoglobulin and thereby to form a complex.

### Claim 5 (depends on 4)

A method as set forth in claim 4, wherein said step of selectively perturbing said evanescent optical field further includes the step of exposing said surface to a solution containing a material tending selectively to bind to said complex.

### Claim 6 (depends on 1)

A method as set forth in claim 1, wherein:
said substrate utilizes total internal reflection to form said evanescent field;
said molecular probe comprises a nucleic acid having a single-stranded segment;
said molecular target comprises a nucleic acid having a single-stranded segment tending to hybridize with said single-stranded segment of said molecular probe and thereby to form a double-stranded segment; and
said step of selectively perturbing said evanescent optical field includes the step of exposing said surface to a mixture containing a mass-amplifying component, said mass-amplifying component comprising a sequence-specific polyamide tending selectively to bind to said double-stranded segment.

### Claim 7 (depends on 6)

A method as set forth in claim 6, wherein said sequence-specific polyamide is bound to a member of the group consisting of: biotin, metallic microspheres, metallic colloid, polystyrene microspheres, nanospheres, avidin, streptavidin, and immunoglobulin.

### Claim 8 (depends on 2)

A method as set forth in claim 2 wherein said immunoglobulin is mouse IgM tending selectively to bind to double-stranded DNA.

### Claim 9

A method of discriminating between binding and nonbinding molecular targets of a molecular probe, the method comprising the steps of:
providing a substrate, said substrate forming a surface;
immobilizing a molecular probe on said surface;
exposing said molecular probe to a solution containing said molecular target;
selectively aggregating at least one high-molecular-weight component on said surface only if said molecular target has bound to said molecular probe;
detecting said high-molecular-weight component on said surface; and
correlating detection of said high-molecular-weight component with binding of said molecular target to said molecular probe.

### Claim 10 (depends on 9)

A method as set forth in claim 9, wherein:
said comprises a planar slide;
said molecular probe comprises a nucleic acid having a single-stranded segment;
said molecular target comprises a nucleic acid having a single-stranded segment tending to hybridize with said single-stranded segment of said molecular probe and thereby to form a double-stranded segment; and
selectively aggregating at least one high-molecular-weight component on said surface includes the step of exposing said surface to a solution containing an immunoglobulin tending selectively to bind to said double-stranded segment.

### Claim 11 (depends on 10)

A method as set forth in claim 10, wherein said step of selectively aggregating at least one high-molecular-weight component on said surface further includes the step of exposing said surface to a solution containing a material tending selectively to bind to said immunoglobulin.

### Claim 12 (depends on 9)

A method as set forth in claim 9, wherein:
said comprises a planar slide;
said molecular probe comprises an immunoglobulin; and
said molecular target comprises an antigen tending to bind to said immunoglobulin and thereby to form a complex.

### Claim 13 (depends on 12)

A method as set forth in claim 12, wherein said step of selectively aggregating at least one high-molecular-weight component on said surface further includes the step of exposing said surface to a solution containing a material tending selectively to bind to said complex.

### Claim 14 (depends on 9)

A method as set forth in claim 9, wherein:
said comprises a planar slide;
said molecular probe comprises a nucleic acid having a single-stranded segment;
said molecular target comprises a nucleic acid having a single-stranded segment tending to hybridize with said single-stranded segment of said molecular probe and thereby to form a double-stranded segment; and
said step of selectively aggregating at least one high-molecular-weight component on said surface includes the step of exposing said surface to a mixture containing a mass-amplifying component, said mass-amplifying component comprising a sequence-specific polyamide tending selectively to bind to said double-stranded segment.

### Claim 15 (depends on 14)

A method as set forth in claim 14, wherein said sequence-specific polyamide is bound to a member of the group consisting of: polyethylene glycol, biotin, metallic microspheres, metallic colloid, polystyrene microspheres, nanospheres, avidin, streptavidin, and immunoglobulin.

### Claim 16 (depends on 10)

A method as set forth in claim 10 wherein said immunoglobulin is mouse IgM tending selectively to bind to double-stranded DNA.

### Claim 17

A method for identifying an active substance in a sample by the reaction of the active substance (target) with its specific binding partner (probe) comprising the steps of:
a. Applying a sample probe material to a substrate;
b. Exposing said probe material to a target material; and
c. Applying a mass amplifier material which specifically binds to combinations of said probe and target materials,
whereby the resultant product of the probe-target combination is a binding site for said mass amplifier material providing a substantially more massive structure at the probe-target combination site, more easily recognized by detecting equipment.

### Claim 18 (depends on 17)

The method of claim 17 wherein said probe material is an oligonucleotide and said target material is an oligonucleotide complementary with said probe material.

### Claim 19 (depends on 18)

The method of claim 18 wherein said mass amplifier material is anti-double stranded DNA mouse IgM.

### Claim 20 (depends on 19)

The method of claim 19 wherein said mass amplifier material is bonded to microspheres.

### Claim 21 (depends on 18)

The method of claim 18, including the additional step of adding a dsDNA-sequence-specific minor-groove-binding molecule bonded to biotin prior to said step of adding a mass amplifier material.

### Claim 22 (depends on 17)

The method of claim 17, including the additional step of applying a secondary amplifier material to target-probe-amplifier combination to provide a more massive combination.

### Claim 23 (depends on 19)

The method of claim 19, including the additional step of applying, as a secondary amplifier material, goat anti-mouse IgM IgG.

### Claim 24 (depends on 21)

The method of claim 21, including the additional step of applying, as a mass amplifier material, streptavidin.

### Claim 25 (depends on 17)

The method of claim 17 wherein said probe material is non-human IgG and said target material is human IgG and said mass amplifier material is non-human anti-human-IgG IgG.

### Claim 26 (depends on 17)

The method of claim 17 wherein said probe material is non-human IgG and said target material is human IgG and said mass amplifier material is non-human anti-human-IgG IgM.

### Claim 27

A bioassay method for identifying a bioactive substance (antigen) comprising the steps of:
a. Fixing a probe (antibody) of the bioactive substance (antigen) to a substrate;
b. Applying the bioactive substance (antigen) to the substrate at the site of said probe (antibody) to form a reaction complex of said antigen and said antibody; and
c. Applying an amplifying complex (primary amplifying antibody) of a bulk and mass substantially greater than either said bioactive substance (antigen) or said probe (antibody) with an affinity for the said reaction complex of said antigen and said antibody;
whereby the reaction complex of said bioactive substance and said probe provides a binding site for said amplifying complex to provide an aggregate structure of mass and bulk substantially greater than the mass and bulk of the reaction complex.

### Claim 28 (depends on 27)

The process of claim 27, further including the step of applying a second amplifying complex (secondary amplifying antibody) of a bulk and mass substantially greater than either said bioactive substance (antigen) or said amplifying complex (primary amplifying antibody); said second amplifying complex (secondary amplifying antibody) binding to said reacted combination and said complex (primary amplifying antibody) to further increase the mass and bulk at the site of the reaction complex.

### Claim 29

Apparatus for identifying unknown target materials comprising;
a. A carrier having a first surface;
b. A plurality of probes each specific for a particular target material arranged in an identifiable subset; and
c. A quantity of mass enhancing amplifier material for forming probe-target-mass-enhancing-amplifier complexes at the site of a probe-target interaction,
whereby the presence of a probe-target interaction at a particular probe site is indicative of the identity of the target material.

### Claim 30

Apparatus for identifying an unknown target material comprising in combination:
a. A carrier having a planar surface;
b. An array of probes immobilized on said surface, each of said probes exhibiting a known reaction with a different target; and
c. A mass enhancing amplifier material having a known unique attraction to combinations of said probes and respective corresponding targets,
whereby an unknown target material reacting with one of said array of probes binds to said mass enhancing amplifier material to create a readily distinguishable mass enhanced reaction product at the reaction site, thus uniquely identifying the unknown target material by the location of the reaction site within said array.

### Claim 31 (depends on 30)

The apparatus of claim 30, wherein said carrier is a glass slide.

### Claim 32 (depends on 30)

The apparatus of claim 30, further including an optical reader including transparent means having a first index of refraction and forming a total internal reflection from a surface thereof, wherein sad carrier has a second surface juxtaposed with said total internal reflection surface.

### Claim 33 (depends on 30)

The apparatus of claim 30, wherein said carrier has an index of refraction chosen to be identical to that of said optical reader.

### Claim 34 (depends on 30)

The apparatus of claim 30, wherein said probe is chosen from a class including oligonucleotides, single stranded DNA (ssDNA), non-human IgG, polymers, DNA-RNA hybrids, locked nucleic acids, polysaccharides, and proteins; wherein said targets are chosen from a class of materials that have a unique affinity for said probes; and wherein said mass-enhancing mass amplifier materials are chosen from a class of materials that have a unique affinity for probe-target combinations, including anti-double-stranded DNA mouse IgM, anti-double-stranded DNA mouse IgM coupled to microspheres, sequence seeker polyamide coupled to biotin, sequence seeker coupled to polyethylene glycol, sequence seeker polyamide coupled to anti-double stranded DNA mouse IgM, sequence seeker polyamide coupled to microspheres, anti-DNA-RNA hybrid mouse IgG, non-human anti-human-IgG IgG and non-human anti-human IgG, IgGM, the combination of probe and target in each instance being capable of producing a probe-target pair with a unique attraction for a mass-enhancing amplifier material selected from said class.

### Claim 35

A method for identifying an unknown target material comprising the steps of:
a. immobilizing an array of probes, each specific for a different target material;
b. applying unknown target material to said array to form at least one probe-target pair; and
c. applying a mass-enhancing amplifier material that is adapted to bind to any formed probe-target pairs;
whereby any probe-target pair that is formed is more easily detected by the combination with the mass-enhancing amplifier material that attaches solely to probe-target pairs.

### Claim 36 (depends on 35)

The method of claim 35, further including the step of applying a secondary mass enhancing amplifier material that is adapted to bond to formed probe-target pairs to which said mass enhancing amplifier material has attached to provide a significantly more massive probe-target site more readily identified by detection devices.

### Claim 37

A bioassay method for identifying a bioactive substance (antibody) comprising the steps of:
a. Fixing a probe (antigen) of the bioactive substance (antibody) to a substrate;
b. Applying the bioactive substance (antibody) to the substrate at the site of said probe (antigen) to form a reaction complex of said antigen and said antibody; and
c. Applying an amplifying complex (primary amplifying antgen) of a bulk and mass substantially greater than either said bioactive substance (antibody) or said probe (antigen) with an affinity for the said reaction complex of said antigen and said antibody;
whereby the reaction complex of said bioactive substance and said probe provides a binding site for said amplifying complex to provide an aggregate structure of mass and bulk substantially greater than the mass and bulk of said reaction complex.

### Claim 38 (depends on 37)

The process of claim 37, further including the step of applying a second amplifying complex (secondary amplifying antigen) of a bulk and mass substantially greater than either said bioactive substance (antibody) or said amplifying complex (primary amplifying antigen); said second amplifying complex (secondary amplifying antigen) binding to said reacted combination and said complex (primary amplifying antigen) to further increase the mass and bulk at the site of said reaction complex.

### Claim 39 (depends on 22)

A method as set forth in claim 22, including the additional step of applying, as a tertiary amplifier material, an immunoglobulin specific to the secondary amplifier material.

### Claim 40 (depends on 39)

A method as set forth in claim 39, wherein the tertiary amplifier material comprises IgM.

### Claim 41 (depends on 24)

A method as set forth in claim 24, including the additional step of applying, as a tertiary amplifier material, a molecule having an affinity for streptavidin.

### Claim 42

Apparatus comprising:
a. a slide having a first surface;
b. an array of DNA Segments (oligomers) immobilized on said surface;
c. matching DNA segments coupled to said oligomers for forming double-stranded hybridized complexes there; and
d. IgM molecules attached to said hybridized complexes.

### Claim 43 (depends on 42)

Apparatus as in claim 42, wherein said IgM molecule is a fluorescent-labeled molecule.

### Claim 44 (depends on 42)

Apparatus as in claim 42, wherein said IgM molecule is a magnetically-labeled molecule.

### Claim 45 (depends on 42)

Apparatus as in claim 42, wherein said IgM molecule is a color-labeled molecule.

### Claim 46 (depends on 42)

Apparatus as in claim 42, wherein said IgM molecule is labeled with high electric-permeability molecules.

### Claim 47 (depends on 42)

Apparatus as in claim 42, wherein said array includes subarrays, each of said subarrays having immobilized there different DNA oligomers, different DNA matching segments coupled to the oligomers of at least one of said subarrays for forming double-stranded hybridized complexes there, said apparatus also including IgM molecules attached only to the hybridized complexes of at least said one of said subarrays.

### Claim 48 (depends on 43)

The apparatus of claim 43, wherein said array includes subarrays, each of said subarrays having immobilized there different DNA oligomers, different DNA matching segments coupled to the oligomers of at least one of said subarrays for forming double-stranded hybridized complexes there, said apparatus also including IgM molecules attached only to the hybridized complexes of at least said one of said subarrays.

### Claim 49 (depends on 44)

The apparatus of claim 44, wherein said array includes subarrays, each of said subarrays having immobilized there different DNA oligomers, different DNA matching segments coupled to the oligomers of at least one of said subarrays for forming double-stranded hybridized complexes there, said apparatus also including IgM molecules attached only to the hybridized complexes of at least said one of said subarrays.

### Claim 50 (depends on 45)

The apparatus of claim 45, wherein said array includes subarrays, each of said subarrays having immobilized there different DNA oligomers, different DNA matching segments coupled to the oligomers of at least one of said subarrays for forming double-stranded hybridized complexes there, said apparatus also including IgM molecules attached only to the hybridized complexes of at least said one of said subarrays.

### Claim 51 (depends on 46)

The apparatus of claim 46, wherein said array includes subarrays, each of said subarrays having immobilized there different DNA oligomers, different DNA matching segments coupled to the oligomers of at least one of said subarrays for forming double-stranded hybridized complexes there, said apparatus also including IgM molecules attached only to the hybridized complexes of at least said one of said subarrays.

### Claim 52

A method for identifying an active substance in a sample by the reaction of the active substance (target) with its specific binding partner (probe) wherein the probe is a DNA segment (oligomer) and the target is a matching DNA segment capable of forming a hybridized (double-strand) complex with the probe, the method comprising the steps of:
a. immobilizing DNA segments (probes) on a carrier;
b. exposing said probes to applied targets for forming hybridized complexes; and
c. applying IgM molecules chosen for their ability to attach only to hybridized complexes.

### Claim 53 (depends on 52)

A method as in claim 52, wherein said IgM is fluorescent-labeled.

### Claim 54 (depends on 52)

A method as in claim 52, wherein said IgM is a magnetically-labeled molecule.

### Claim 55 (depends on 52)

A method as in claim 52, wherein said IgM is a color-labeled molecule.

### Claim 56 (depends on 52)

A method as in claim 52, wherein said IgM is labeled with high electric-permeability molecules.

### Claim 57 (depends on 1)

A method as set forth in claim 1, wherein said molecular probe comprises a locked nucleic acid.

### Claim 58 (depends on 1)

A method as set forth in claim 1, wherein:
said substrate utilizes total internal reflection to form said evanescent field;
said molecular probe comprises a nucleic acid having a single-stranded segment;
said molecular target comprises a nucleic acid having a single-stranded segment tending to hybridize with said single-stranded segment of said molecular probe and thereby to form a double-stranded segment; and
said step of selectively perturbing said evanescent optical field includes the step of exposing said surface to a solution containing a molecule tending selectively to bind to said double-stranded segment.

### Claim 59 (depends on 58)

A method as set forth in claim 58, wherein said molecule tending selectively to bind to said double-stranded segment comprises a molecule selected from the group consisting of:
dsDNA-specific IgG,
dsDNA-specific Fab fragment,
dsDNA-specific F(ab′)2 fragment,
DNA-RNA-hybrid-specific IgG,
DNA-RNA-hybrid-specific Fab fragment,
DNA-RNA-hybrid-specific F(ab′)2 fragment,
DNA-LNA-hybrid-specific IgG,
DNA-LNA-hybrid-specific Fab fragment,
DNA-LNA-hybrid-specific F(ab′)2 fragment,
dsDNA-specific IgM tetramer,
dsDNA-specific IgM monomer,
dsDNA-specific IgM Fab fragment, and
dsDNA-specific IgM F(ab′)2 fragment.

### Claim 60 (depends on 1)

A method as set forth in claim 1, wherein:
said substrate utilizes total internal reflection to form said evanescent field;
said molecular probe comprises a polysaccharice; and
said molecular target comprises an immunoglobulin tending to bind to said molecular probe and thereby to form a complex.

### Claim 61 (depends on 60)

A method as set forth in claim 60, wherein said step of selectively perturbing said evanescent optical field further includes the step of exposing said surface to a solution containing a material tending selectively to bind to said complex.
